Advances in Cardiomyopathies: Proceedings of the II Florence Meeting on Advances on Cardiomyopathies April 24-26, 1997

ISBN-13: 9788847021815 / Angielski / Miękka / 2012 / 317 str.

Fulvio Camerini; Antonello Gavazzi; Renata DeMaria

Opis

The Italian Study Group on Cardiomyopathies organized in Florence in April 1997, eight years after the first successful meeting, the second international symposium devoted to "Advances in Cardiomyopathies." In these years exceptional progress has been made in the field of heart muscle diseases, in clinical research as well as in molecular biology, molec ular genetics., pathophysiology and treatment. Many of these advances were presented and discussed in Florence by a distinguished team of international experts. Hypertrophic cardiomyopathy was addressed in ten papers; in the first one Seidman reported the results obtained by the use of molecular genetic tech niques which showed that hypertrophic cardiomyopathy is a heterogeneous disorder caused by different mutations of different genes and discussed the clinical role and significance of genetic testing. Original data regarding the natural history and prognosis of symptomatic patients were obtained in the Italian multicentric study (Cecchi, Lazzeroni), while Baroldi discussed the clinico-pathologic spectrum of the disease in severely symptomatic patients treated with heart transplantation. Sudden death in the young (Basso), the identification and management of high risk patients (Elliott), the clinical importance and the problems of detec tion of ischemia (Camici) were deeply discussed as well as the indications and results of different types of treatment: medical, surgical, DDD pacing (Spirito, Betocchi, Schoendube)."

Spis treści

Introduction: II Florence Meeting on Advances in Cardiomyopathies The Clinical Significance of Genetic Testing in Familial Hypertrophic Cardiomyopathy The Italian Multicentric Study on Hypertrophic Cardiomyopathy: I.Natural History and Clinical Course of Unselected Patients Detection and Clinical Consequences of Myocardial Ischemia and, Reduced Coronary Reserve The Coronary Circulation is Dysfunctional in both Hypertrophied and Non-Hypertrophied Myocardium Hypertrophic Cardiomyopathy and Sudden Death in the Young: a Pathologist's View Identification and Management of High Risk Patients with Hypertrophic Cardiomyopathy The Italian Multicentric Study on Hypertrophic Cardiomyopathy: II. Prognostic Assessment in Symptomatic Patients Medical Treatment of Heart Failure in Hypertrophic Cardiomyopathy DDD Pacing in HCM: State of the Art Indications and Outcome of Cardiac Surgery for Severely Symptomatic Patients with Hypertrophic Obstructive Cardiomyopathy Genetic Basis of Dilated Cardiomyopathy Virus Infection in Cardiomyopathies: Brief Overview, Recent Advances Organ-specific Cardiac Autoantibodies in Dilated Cardiomyopathy: Pathogenetic Implications Inflammatory Cardiomyopathy: Diagnosis and Therapeutical Options Pathophysiologic Role of Coronary Microcirculatory Impairment in Dilated Cardiomyopathy Molecular Biology of Cardiac Failure Dilated Cardiomyopathy: does Etiological Heterogeneity Portend Clinical Heterogeneity? The Natural History of Dilated Cardiomyopathy. The SPIC Registry 1986-1995. Therapeutic Strategies in Dilated Cardiomyopathy: Immunosuppressive Treatment for Inflammatory Dilated Cardiomyopathy (Myocarditis) Prevention of Sudden Death in Patients with Dilated Cardiomyopathy End-Stage Heart Failure and Timing of Heart Transplantation Beta-Blockers for Heart Failure: Practical Issues DDD Pacing in Dilated Cardiomyopathy Cardiomyoplasty: Surgical Therapy for Ischemic and Idiopathic Dilated Cardiomyopathies .